Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
The price of Seres Therapeutics Inc (NASDAQ: MCRB) closed at $0.81 in the last session, down -2.19% from day before closing price of $0.83. In other words, the price has decreased by -$2.19 from its previous closing price. On the day, 0.65 million shares were traded.
Ratios:
We take a closer look at MCRB’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 1.12 and its Current Ratio is at 1.12. In the meantime, Its Debt-to-Equity ratio is 3.91 whereas as Long-Term Debt/Eq ratio is at 3.56.
On April 21, 2023, JP Morgan started tracking the stock assigning a Neutral rating and target price of $7.JP Morgan initiated its Neutral rating on April 21, 2023, with a $7 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Feb 18 ’25 when Young Teresa L. sold 3,338 shares for $0.81 per share. The transaction valued at 2,704 led to the insider holds 97,536 shares of the business.
Henn Matthew R. sold 3,953 shares of MCRB for $3,204 on Feb 18 ’25. The insider now owns 84,443 shares after completing the transaction at $0.81 per share. On Feb 18 ’25, another insider, Shaff Eric D., who serves as the CEO and President of the company, sold 12,726 shares for $0.81 each. As a result, the insider received 10,314 and left with 192,039 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 2309.54 while its Price-to-Book (P/B) ratio in mrq is 5.78.
Stock Price History:
Over the past 52 weeks, MCRB has reached a high of $1.53, while it has fallen to a 52-week low of $0.54. The 50-Day Moving Average of the stock is -4.06%, while the 200-Day Moving Average is calculated to be -9.12%.
Shares Statistics:
A total of 170.20M shares are outstanding, with a floating share count of 124.86M. Insiders hold about 26.87% of the company’s shares, while institutions hold 23.42% stake in the company.
Earnings Estimates
Its stock is currently analyzed by 4.0 different market analysts. The consensus estimate for the next quarter is -$0.19, with high estimates of -$0.12 and low estimates of -$0.26.
Analysts are recommending an EPS of between -$0.11 and -$0.94 for the fiscal current year, implying an average EPS of -$0.52. EPS for the following year is -$0.41, with 4.0 analysts recommending between -$0.02 and -$0.82.
